1. Leem JH, Cho JH, Lee EC, Kim JH, Lee DH, Lee SJ, Lee JY, Kim HC. Clusters of pneumoconiosis among residents near cement factories. Korean J Occup Environ Med. 2010; 22(2):140–145.
2. Van Oss H, Padovani AC. Cement manufacture and the environment: part I: chemistry and technology. J Ind Ecol. 2002; 6(1):89–105. DOI:
10.1162/108819802320971650.
3. Meo SA. Health hazards of cement dust. Saudi Med J. 2004; 25(9):1153–1159. PMID:
15448758.
4. Van Oss H, Padovani AC. Cement manufacture and the environment: part II: environmental challenges and opportunities. J Ind Ecol. 2003; 7(1):93–126. DOI:
10.1162/108819803766729212.
5. Abrons HL, Petersen MR, Sanderson WT, Engelberg AL, Harber P. Chest radiography in Portland cement workers. J Occup Environ Med. 1997; 39(11):1047–1054. DOI:
10.1097/00043764-199711000-00005. PMID:
9424275.
6. Smailyte G, Kurtinaitis J, Andersen A. Mortality and cancer incidence among Lithuanian cement producing workers. Occup Environ Med. 2004; 61(6):529–534. DOI:
10.1136/oem.2003.009936. PMID:
15150393.
7. Dietz A, Ramroth H, Urban T, Ahrens W, Becher H. Exposure to cement dust, related occupational groups and laryngeal cancer risk: results of a population based case‐control study. Int J Cancer. 2004; 108(6):907–911. DOI:
10.1002/ijc.11658. PMID:
14712496.
10. Wang B Jr, Wu J-D, Sheu S-C, Shih T-S, Chang H-Y, Guo Y-L, Wang Y-J, Chou T-C. Occupational hand dermatitis among cement workers in Taiwan. J Formos Med Assoc. 2011; 110(12):775–779. DOI:
10.1016/j.jfma.2011.11.008. PMID:
22248832.
11. Al-Neaimi Y, Gomes J, Lloyd O. Respiratory illnesses and ventilatory function among workers at a cement factory in a rapidly developing country. Occup Med. 2001; 51(6):367–373. DOI:
10.1093/occmed/51.6.367.
12. Merenu I, Mojiminiyi F, Njoku C, Ibrahim M. The effect of chronic cement dust exposure on lung function of cement factory workers in sokoto, Nigeria. Afr J Biomed Res. 2007; 10(2):139–143.
13. Mirzaee R, Kebriaei A, Hashemi S, Sadeghi M, Shahrakipour M. Effects of exposure to Portland cement dust on lung function in Portland cement factory workers in Khash, Iran. IJEHSE. 2008; 5(3):201–206.
14. Poornajaf A, Kakooei H, Hosseini M, Ferasati F, Kakaei H. The effect of cement dust on the lung function in a cement factory, Iran. IJOH. 2010; 2(2):4–8.
15. Zeleke ZK, Moen BE, Bratveit M. Cement dust exposure and acute lung function: a cross shift study. BMC Pulm Med. 2010; 10:19. DOI:
10.1186/1471-2466-10-19. PMID:
20398255.
16. Nordby K-C, Fell AKM, Notø H, Eduard W, Skogstad M, Thomassen Y, Bergamaschi A, Kongerud J, Kjuus H. Exposure to thoracic dust, airway symptoms and lung function in cement production workers. Eur Respir J. 2011; 38(6):1278–1286. DOI:
10.1183/09031936.00007711. PMID:
21659410.
17. Ahmed HO, Abdullah AA. Dust exposure and respiratory symptoms among cement factory workers in the United Arab Emirates. Ind Health. 2012; 50(3):214–222. DOI:
10.2486/indhealth.MS1320. PMID:
22453209.
18. Kumagai S, Kurumatani N. Asbestos fiber concentration in the area surrounding a former asbestos cement plant and excess mesothelioma deaths in residents. Am J Ind Med. 2009; 52(10):790–798. DOI:
10.1002/ajim.20743. PMID:
19728322.
19. Musti M, Pollice A, Cavone D, Dragonieri S, Bilancia M. The relationship between malignant mesothelioma and an asbestos cement plant environmental risk: a spatial case-control study in the city of Bari (Italy). Int Arch Occup Environ Health. 2009; 82(4):489–497. DOI:
10.1007/s00420-008-0358-5. PMID:
18810484.
20. Gbadebo A, Bankole O. Analysis of potentially toxic metals in airborne cement dust around Sagamu, southwestern Nigeria. J Appl Sci. 2007; 7(1):35–40. DOI:
10.3923/jas.2007.35.40.
21. Cha KT, Oh SS, Yoon JH, Lee KH, Kim SK, Cha BS, Kim SH, Eom AY, Koh SB. Adverse health outcomes in residents exposed to cement dust. J Toxicol Environ Health Sci. 2011; 3(4):239–244. DOI:
10.1007/s13530-011-0101-6.
22. KOSHA. The technical guideline on pulmonary function test and interpretation KOSHA GUIDE. 2013. Korean: ᅟ;p. H-110-2013.
23. FORCE AET, Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CM, Gustafsson P. General considerations for lung function testing. Eur Respir J. 2005; 26(1):153–161. DOI:
10.1183/09031936.05.00034505. PMID:
15994402.
25. FORCE AET, Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, Van Der Grinten C, Gustafsson P. Standardisation of spirometry. Eur Respir J. 2005; 26(2):319–338. DOI:
10.1183/09031936.05.00034805. PMID:
16055882.
26. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013; 187(4):347–365. DOI:
10.1164/rccm.201204-0596PP. PMID:
22878278.
27. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis (Seoul). 2005; 58(3):230–242.
29. Ling SH, van Eeden SF. Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2009; 4:233–243. DOI:
10.2147/COPD.S5098. PMID:
19554194.
30. Burnett RT, Pope CA, Ezzati M, Olives C, Lim SS, Mehta S, Shin HH, Singh G, Hubbell B, Brauer M, Anderson HR, Smith KR, Balmes JR, Bruce NG, Kan H, Laden F, Pruss-Ustun A, Turner MC, Gapstur SM, Diver WR, Cohen A. An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ Health Perspect. 2014; 122(4):397–403. PMID:
24518036.
31. Khang Y-H, Cho H-J. Socioeconomic inequality in cigarette smoking: trends by gender, age, and socioeconomic position in South Korea, 1989-2003. Prev Med. 2006; 42(6):415–422. DOI:
10.1016/j.ypmed.2006.02.010. PMID:
16580714.
33. Ling SH, McDonough JE, Gosselink JV, Elliott WM, Hayashi S, Hogg JC, van Eeden SF. Patterns of retention of particulate matter in lung tissues of patients with COPD. Chest. 2011; 140(6):1540–1549. DOI:
10.1378/chest.10-2281. PMID:
21659433.
34. Tilert T, Dillon C, Paulose-Ram R, Hnizdo E, Doney B. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Respir Res. 2013; 14:103. DOI:
10.1186/1465-9921-14-103. PMID:
24107140.
35. Tan WC, Vollmer WM, Lamprecht B, Mannino DM, Jithoo A, Nizankowska-Mogilnicka E, Mejza F, Gislason T, Burney PG, Buist AS. Worldwide patterns of bronchodilator responsiveness: results from the burden of obstructive lung disease study. Thorax. 2012; 67(8):718–726. DOI:
10.1136/thoraxjnl-2011-201445. PMID:
22544896.
36. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. The Lancet. 2007; 370(9589):765–773. DOI:
10.1016/S0140-6736(07)61380-4.
37. FORCE AET, Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R, Coates A, Van der Grinten C, Gustafsson P, Hankinson J. Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948–968. DOI:
10.1183/09031936.05.00035205. PMID:
16264058.
38. Esmaeil N, Gharagozloo M, Rezaei A, Grunig G. Dust events, pulmonary diseases and immune system. Am J Clin Exp Immunol. 2014; 3(1):20. PMID:
24660118.
39. FORCE AET, Wanger J, Clausen J, Coates A, Pedersen O, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Van Der Grinten C. Standardisation of the measurement of lung volumes. Eur Respir J. 2005; 26(3):511–522. DOI:
10.1183/09031936.05.00035005. PMID:
16135736.
40. Sterk P. Let's not forget: the GOLD criteria for COPD are based on post-bronchodilator FEV1. Eur Respir J. 2004; 23(4):497–498. DOI:
10.1183/09031936.04.00017104. PMID:
15083741.